Login

Vaccine Maker Breaks Ground on Manufacturing Facility in North Houston

VGXI Inc.'s 240,000-Square-Foot Facility Expected to Open in 2022
VGXI Inc.'s new greenfield site could help to elevate Houston's profile in the life science sector. (VGXI Inc.)
VGXI Inc.'s new greenfield site could help to elevate Houston's profile in the life science sector. (VGXI Inc.)
CoStar News
November 12, 2020 | 12:24 AM

A gene therapy and vaccine maker has broken ground on a 240,000-square-foot manufacturing and headquarters facility in the Houston area in the latest boost to the city's life science sector.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In